InflaRx N.V. (IFRX)

NMS – Цена в реальном времени. Валюта: USD

2.00

-0.01 (-0.25%)

Рынок открыт: Aug 12, 2026, 3:47 PM EDT

2.03

+0.03 (1.50%)

Предыдущая сессия: Aug 11, 2026, 7:34 PM EDT

06.08.2026

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Announced advancement of izicopan in ANCA-associated vasculitis (AAV) and select renal diseases; clinical preparations ongoing as planned Initiated feasibility assessment for broadened strategy for AAV in Europe Reported new pre-clinical data supporting the safety and differentiation of izicopan as a next-generation oral inhibitor of C5aR Pharmacokinetic (PK) bridging study in China expected to start late this year, with a goal to accelerate izicopan proof-of-concept studies in additional inflammation and immunology (I&I) indications Virtual Capital Markets Day planned for October 8, 2026 in the morning ET Cash, cash equivalents and marketable securities totaled €158.4 million on June 30, 2026, including net proceeds from the underwritten public offering completed in May, expected to fund ongoing operations and clinical development through 2029 Jena, Germany, Aug. 06, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced financial results for the three months ended June 30, 2026, and provided a business update.

Видео

No Data

There is no data to display

Пресс-релизы

06.08.2026

InflaRx N.V. (IFRX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

InflaRx N.V. (IFRX)

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Видео

No Data

Пресс-релизы

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Видео

No Data

Пресс-релизы

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Search stocks

InflaRx N.V. (IFRX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

InflaRx N.V. (IFRX)

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Видео

No Data

Пресс-релизы

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Видео

No Data

Пресс-релизы

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones